About Hilary Weingarden, PhD

Hilary Weingarden, Ph.D. is an Assistant Professor at Harvard Medical School, a psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH), and Assistant Director of the MGH Center for Digital Mental Health. Dr. Weingarden received her bachelor’s degree from Tufts University and her Ph.D. in clinical psychology from George Mason University. She completed her pre- and post-doctoral training at MGH/Harvard Medical School, within the Center for OCD and Related Disorders (CORD) and is a licensed psychologist in the state of Massachusetts.

Dr. Weingarden's research is focused on cognitive and emotional risk factors for adverse outcomes such as suicide risk in OCD and body dysmorphic disorder (BDD). Her research also focuses on applying technology to enhance assessment of and interventions for OCD and related disorders. Her work has been supported as Principal Investigator by the National Institute of Mental Health, Harvard Medical School, and as a co-Investigator on industry collaborations. In addition to her work at MGH, she has a private practice where she provides evidence-based psychological treatments for adults with OCD, anxiety, body-focused repetitive behaviors, and related disorders.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Psychiatry: Adult Outpatient Psychiatry Services
55 Fruit St.
Wang Ambulatory Care Center
Boston, MA 02114
Phone: 617-643-6206

Medical Education

  • PhD, George Mason University

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Weingarden's research interests are broadly focused on cognitive and emotional risk factors for poor psychosocial outcomes in individuals with obsessive-compulsive related disorders (OCRDs) and body image disturbances. She is particularly interested in the roles of shame and other non-anxiety emotions (e.g., disgust, guilt) in OCRDs. Dr. Weingarden is also interested in issues of access to evidence-based treatments and how technology may be used to improve treatment access.

Publications

  • Selected publications:

    Weingarden, H. , Garriga Calleja, R., Greenberg, J. L., Snorrason, I., Matic, A., Quist, R., Harrison, O., Hoeppner, S. S., & Wilhelm, S. (2023). Characterizing observed and effective behavioral engagement with smartphone cognitive behavioral therapy for body dysmorphic disorder: A methods roadmap and use case. Internet Interventions, 32, doi: 101.1016/j.invent.2023.100615.

    Weingarden, H. , Wilhelm, S., Jacobs, J. M., Carrellas, J., Cetrulo, C., Austen, W. G. Jr., & Colwell, A. S. (2022). Prospective examination of psychological risk and maintenance factors for body image distress after mastectomy with immediate breast reconstruction. Body Image, 42, 120-125. doi: 10.1016/j.bodyim.2022.05.014.

    Wilhelm, S., Weingarden, H. , Greenberg, J. L., Hoeppner, S. S., Snorasson, I., Bernstein, E. E., McCoy, T. H., & Harrison, O. (2022). Efficacy of app-based cognitive behavioral therapy for body dysmorphic disorder with coach support: Initial randomized controlled clinical trial. Psychotherapy and Psychosomatics, 91, 277-285. doi: 10.1159/000524628

    Bernstein, E. E., Weingarden, H. , Wolfe, E., Hall, M. D., Snorrason, I., & Wilhelm, S. (2022). Human support in app-based cognitive behavioral therapies for emotional disorders: A scoping review. Journal of Medical Internet Research, 24, e33307. doi:10.2196/33307

    Weingarden, H. , Hoeppner, S. S., Snorrason, I., Greenberg, J. L., Phillips, K. A., & Wilhelm, S. (2021). Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder. Depression & Anxiety, 38: 700-707. doi: 10.1002/a.23148

    ?Greenberg, J. L., ?Weingarden, H. , & Wilhelm, S. (2019). A practical guide to managing body dysmorphic disorder in the cosmetic surgery setting. JAMA Facial Plastic Surgery, 21, 181-182. doi: 10.1001/jamafacial.2018.1840.?Co-first authors

Reviews: Comments and Ratings